Wall Street analysts have set a consensus EPS estimate of $1.91, reflecting a 5.5% year-over-year increase, alongside a revenue target of $6.92 billion, up 3.7% from the previous year
Source link
Gilead Sciences shares decline 1.36% ahead of first quarter earnings | Stock Market News
